{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:01:07Z","timestamp":1747206067231,"version":"3.40.5"},"reference-count":7,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEOR"],"DOI":"10.2147\/ceor.s363642","type":"journal-article","created":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:40:06Z","timestamp":1649036406000},"page":"163-165","source":"Crossref","is-referenced-by-count":0,"title":["Economic Analysis of Intravenous Iron in Patients with Iron Deficiency Anemia Due to Inflammatory Bowel Disease: Considerations for Clinicians [Letter]"],"prefix":"10.2147","volume":"Volume 14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9873-7507","authenticated-orcid":true,"given":"Richard F","family":"Pollock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8964-2031","authenticated-orcid":true,"given":"Anjan","family":"Dhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,4]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2147\/CEOR.S306823","volume":"13","author":"Aksan","year":"2021","journal-title":"Clinicoecon Outcomes Res"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1111\/apt.14043","volume":"45","author":"Aksan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1007\/s12325-019-00993-8","volume":"36","author":"Pollock","year":"2019","journal-title":"Adv Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1001\/jama.2019.22450","volume":"323","author":"Wolf","year":"2020","journal-title":"JAMA"},{"key":"ref5","unstructured":"EU Clinical Trials Register. Clinical Trial Results: a randomized, double-blinded, comparative trial comparing the incidence of hypophosphatemia in relation to repeated treatment courses of iron isomaltoside and ferric carboxymaltose in subjects with iron deficiency anaemia due to inflammatory bowel disease. EudraCT number: 2017-002452-87. Available from: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/trial\/2017-002452-87\/results. Accessed September 25, 2021."},{"key":"ref6","unstructured":"European Medicines Agency. Scientific conclusions and grounds for the variation to the terms of the Marketing Authorisation(s). Available from: https:\/\/www.ema.europa.eu\/en\/documents\/psusa\/iron-parenteral-preparations-except-iron-dextran-cmdh-scientific-conclusions-grounds-variation\/00010236\/202001_en.pdf. Accessed November 3, 2021."},{"key":"ref7","unstructured":"GOV.UK. Drug Safety Update. Ferric carboxymaltose (Ferinject\u25bc): risk of symptomatic hypophosphataemia leading to osteomalacia and fractures; 2020. https:\/\/www.gov.uk\/drug-safety-update\/ferric-carboxymaltose-ferinject-risk-of-symptomatic-hypophosphataemia-leading-to-osteomalacia-and-fractures. Accessed November 3, 2021."}],"container-title":["ClinicoEconomics and Outcomes Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=79593","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=79593","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:40:16Z","timestamp":1649036416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/economic-analysis-of-intravenous-iron-in-patients-with-iron-deficiency-peer-reviewed-fulltext-article-CEOR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":7,"URL":"https:\/\/doi.org\/10.2147\/ceor.s363642","relation":{},"ISSN":["1178-6981"],"issn-type":[{"type":"electronic","value":"1178-6981"}],"subject":[],"published":{"date-parts":[[2022,4]]}}}